Skip to content

Topical Application of Essential Oils to Treat Onchomycosis

Use of Topical Essential Oil Compound to Treat Toe Nail Onychomycosis

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06417983
Acronym
NailFungus
Enrollment
50
Registered
2024-05-16
Start date
2024-05-30
Completion date
2024-11-01
Last updated
2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fungal Infection, Onychomycosis of Toenail, Toenail Infection

Brief summary

Patients with documented onychomycosis of one or more toe nails will be treated with a daily application of a topical lacquer containing several essential oils.

Detailed description

The topical lacquer contains the following components: Active ingredients: Hydroxypropyl Chitosan OLEOZON(r) - natural, ozonized sunflower oil. Vitamin E Tea Tree Oil Cannabidiol Vehicle: Nanoparticle medium chain triglyceride oil

Interventions

None listed

Sponsors

Medical Life Care Planners, LLC
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Clinician observation consistent with probable onychomycosis of one or more toenails. Positive polymerase chain reaction (PCR) for fungal infection or Positive Periodic Acid Schiff, Biopsy, KOH or Culture for fungal infection -

Exclusion criteria

Unwlling to discontinue current anti-fungal medication, oral or topical \-

Design outcomes

Primary

MeasureTime frameDescription
Change in Thickness of the Hyponychium Fungal Infection12 weeksObjective change in the thickness of the hyponychium of the most infected nailplate. The hyponycium will be measured with a micometer thickness guage in micrometer gradations at baseline, 2,5,9 and 12 weeks.
Subject Perceived Improvement in overall toenail infection12 weeksSubject's personal perception of improvement of all infected toenails using the OnyCOE-t questionnaire for patient reported outcomes for toenail onychomycosis at baseline, 2,5 ,9 and 12 weeks of treatment.

Contacts

Primary ContactAndronica Handie, DPM
disabilityevaluators@gmail.com9189944000
Backup ContactGregory L Smith
DrSmith@NeX-Therapeutics.com4044514045

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026